Loading...

Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports

OBJECTIVE: Lung cancer remains the leading cause of malignant tumor-related death globally. There is mounting evidence that a large proportion of patients harboring epidermal growth factor receptor (EGFR) mutation and treated with EGFR TKI experience oligoprogressive disease. The optimal treatment s...

Full description

Saved in:
Bibliographic Details
Published in:Onco Targets Ther
Main Authors: Shi, Xuefei, Zhou, Jia, Qian, Caihua, Gao, Liliang, Wang, Bin, Feng, Xueren
Format: Artigo
Language:Inglês
Published: Dove 2020
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7369376/
https://ncbi.nlm.nih.gov/pubmed/32764966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S257431
Tags: Add Tag
No Tags, Be the first to tag this record!